JP2017132756A5 - - Google Patents

Download PDF

Info

Publication number
JP2017132756A5
JP2017132756A5 JP2017006574A JP2017006574A JP2017132756A5 JP 2017132756 A5 JP2017132756 A5 JP 2017132756A5 JP 2017006574 A JP2017006574 A JP 2017006574A JP 2017006574 A JP2017006574 A JP 2017006574A JP 2017132756 A5 JP2017132756 A5 JP 2017132756A5
Authority
JP
Japan
Prior art keywords
sensation
improving
food
equilibrium
milk fat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017006574A
Other languages
Japanese (ja)
Other versions
JP6941445B2 (en
JP2017132756A (en
Filing date
Publication date
Application filed filed Critical
Publication of JP2017132756A publication Critical patent/JP2017132756A/en
Publication of JP2017132756A5 publication Critical patent/JP2017132756A5/ja
Application granted granted Critical
Publication of JP6941445B2 publication Critical patent/JP6941445B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (7)

乳脂肪球皮膜を有効成分とする平衡感覚改善剤。   An equilibrium sensation improver containing a milk fat globule film as an active ingredient. 乳脂肪球皮膜を有効成分とする平衡感覚改善用食品。 A food for improving the sense of equilibrium containing a milk fat globule film as an active ingredient . 乳脂肪球皮膜が、リン脂質を５〜１００質量％含有する請求項１記載の平衡感覚改善剤又は請求項２記載の平衡感覚改善用食品。 Milk fat globule membrane is balanced sensation-improving agent or Claim 2 balancing sensation-improving food according to claim 1, wherein the phosphorus-containing lipid 5 to 100 wt%. 乳脂肪球皮膜が、スフィンゴミエリンを１〜５０質量％含有する請求項１記載の平衡感覚改善剤又は請求項２記載の平衡感覚改善用食品。 The equilibrium sensation improver according to claim 1 or the food for improving balance sensation according to claim 2 , wherein the milk fat globule membrane contains 1 to 50% by mass of sphingomyelin. 剤型が経口投与用の固形製剤である請求項１〜４のいずれか１項記載の平衡感覚改善剤又は平衡感覚改善用食品。 The agent for improving equilibrium sensation or the food for improving equilibrium sensation according to any one of claims 1 to 4 , wherein the dosage form is a solid preparation for oral administration. 固形製剤が錠剤である請求項５記載の平衡感覚改善剤又は平衡感覚改善用食品。 6. The equilibrium sensation improving agent or the food for improving equilibrium sensation according to claim 5 , wherein the solid preparation is a tablet. 成人１人あたり１日にスフィンゴミエリンを１０〜１５００ｍｇ投与又は摂取するものである請求項１〜６のいずれか１項記載の平衡感覚改善剤又は平衡感覚改善用食品。 The balanced sensation-improving agent or food for improving balanced sensation according to any one of claims 1 to 6 , wherein 10 to 1500 mg of sphingomyelin is administered or ingested per adult per day.
JP2017006574A 2016-01-22 2017-01-18 Balance sensation improver Active JP6941445B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016010542 2016-01-22
JP2016010542 2016-01-22

Publications (3)

Publication Number Publication Date
JP2017132756A JP2017132756A (en) 2017-08-03
JP2017132756A5 true JP2017132756A5 (en) 2020-02-06
JP6941445B2 JP6941445B2 (en) 2021-09-29

Family

ID=59503341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017006574A Active JP6941445B2 (en) 2016-01-22 2017-01-18 Balance sensation improver

Country Status (1)

Country Link
JP (1) JP6941445B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7139727B2 (en) * 2018-06-29 2022-09-21 キリンホールディングス株式会社 COMPOSITION FOR IMPROVING MOTOR CONTROL FUNCTION AND MOTOR LEARNING FUNCTION

Similar Documents

Publication Publication Date Title
JP2015083580A5 (en)
EA202090573A1 (en) COMPOSITIONS OF NIRAPARIBA
JP2014198723A5 (en)
EA201590449A1 (en) ORAL PREPARED MEDICINE COMPOSITION
EA201691226A1 (en) Oral disintegrating solid dosage unit containing esthetic component
JP2013544290A5 (en)
MX2017013636A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from different particles.
Lee et al. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages
JP2019518022A5 (en)
JP2017132756A5 (en)
MX2017005163A (en) Onapristone extended-release compositions and methods.
PH12014502836B1 (en) Medicament form for release of active ingredients
MX2017013633A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles.
RU2020123405A (en) MEDICINAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF SECONDARY HYPERPARATHYROISIS DURING MAINTENANCE DIALYSIS
RU2014146562A (en) ALPHA-LIPOIC ACID AND RACNOCIOLE COMPOSITION FOR THE TREATMENT OF NEUROPATHIES
JP2015523388A5 (en)
JP2017052778A5 (en)
JP2014141476A5 (en)
HRP20201518T1 (en) Pharmaceutical composition comprising bisoprolol and perindoril
MX2017000384A (en) Capsule dosage form of metoprolol succinate.
JP2020040998A5 (en)
WO2009004039A3 (en) Hard gelatin capsule formulation comprising a pumpkin product
JP2013079218A5 (en)
JP2015515971A5 (en)
WO2016197944A1 (en) Uses of antidepressant compound in preparation of antidepressant drugs and antidepressant health foods